TEX13B

Across TCGA pan-cancer cohorts, TEX13B Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated TEX13B data layer compared with 16 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher TEX13B Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated TEX13B expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, LUAD, and BLCA are the cancer types where TEX13B Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	1.000	0.626	.008	30	view →
LUAD	OS	Median	II,III,IV	0.135	0.715	<.001	27	view →
BLCA	OS	Median	All	0.082	0.688	<.001	24	view →
CESC	DFS	Median	All	0.193	0.740	.012	12	view →
COAD	OS	Median	III,IV	0.163	0.791	.004	6	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

TEX13B–UCEC (DFS)

Open the UCEC breakdown →